Prestige Consumer Healthcare (NYSE:PBH) Q3 2026 Earnings call February 05, 2026 08:30 AM ET Speaker1day and thank you for standing by. Welcome to the third quarter, 2026, Prestige Consumer Healthcare Inc. earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your ha ...

Alico (NasdaqGS:ALCO) Q1 2026 Earnings call February 05, 2026 08:30 AM ET Speaker4Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero and a member of our team will be happy to help you. Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero and a member of our team will be happy to help you.Please stand by. Your meeting is about to begin. Good morning, an ...

MasterCraft Boat (NasdaqGM:MCFT) Q2 2026 Earnings call February 05, 2026 08:30 AM ET Speaker9Ladies and gentlemen, thank you for standing by, and welcome to the MasterCraft Boat Holdings Fiscal Second Quarter 2026 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press star one one on ...

Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 05, 2026 08:15 AM ET Company ParticipantsJames Gordon - Director, Head of European Pharma and Biotech & Life Sciences Equity ResearchKarsten Munk Knudsen - CFOMartin Holst Lange - Chief Scientific OfficerMike Doustdar - CEOSachin Jain - European Healthcare Equity ResearchSimon Baker - Head of Global Biopharma ResearchConference Call ParticipantsEvan Seigerman - Managing Director, Head of Healthcare Research, Senior Biotechnology and Pharmaceutical Analy ...

Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 05, 2026 08:15 AM ET Company ParticipantsJames Gordon - Director, Head of European Pharma and Biotech & Life Sciences Equity ResearchKarsten Munk Knudsen - CFOMartin Holst Lange - Chief Scientific OfficerMike Doustdar - CEOSachin Jain - European Healthcare Equity ResearchSimon Baker - Head of Global Biopharma ResearchConference Call ParticipantsEvan Seigerman - Managing Director, Head of Healthcare Research, Senior Biotechnology and Pharmaceutical Analy ...

Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 05, 2026 08:15 AM ET Speaker1Good afternoon, everyone. I'm James Quigley, European Pharma Analyst here at Goldman Sachs, and it's a pleasure to welcome you to this fourth-quarter results presentation for Novo Nordisk. We've got the pleasure to be joined by Mike Doustdar, CEO; Karsten Munk Knudsen, CFO; and Martin Holst Lange, the Chief Scientific Officer. So with that, Mike, thanks for joining us. Over to you.Speaker5Thank you very much for hosting us. ...

Everest Group (NYSE:EG) Q4 2025 Earnings call February 05, 2026 08:00 AM ET Company ParticipantsJim Williamson - President and CEOMark Kociancic - EVP and CFOMatthew Jay Rohrmann - SVP, Head of Investor RelationsConference Call ParticipantsBrian Robert Meredith - AnalystCharles Gregory Peters - AnalystElyse Beth Greenspan - AnalystRyan Tunis - AnalystMark KociancicGood morning and welcome to the Everest Group, Ltd. 4th quarter of 2025 earnings conference call. All participants will be in listen-only mode. S ...

BCE (NYSE:BCE) Q4 2025 Earnings call February 05, 2026 08:00 AM ET Company ParticipantsBatya Levi - Managing DirectorChris Summers - Head of Investor RelationsCurtis Millen - CFOMaher Yaghi - Managing DirectorMirko Bibic - President and CEOConference Call ParticipantsJerome Dubreuil - Research AnalystMatthew Griffiths - Research AnalystSebastiano Petti - Senior Research AnalystStephanie Price - Equity Research AnalystTim Casey - AnalystVince Valentini - AnalystOperatorGood morning, ladies and gentlemen. Wel ...

DHT (NYSE:DHT) Q4 2025 Earnings call February 05, 2026 08:00 AM ET Company ParticipantsEirik Haavaldsen - Head of ResearchGeoff Scott - PresidentGreg Lewis - Managing DirectorJon Chappell - Senior Managing DirectorLaila Halvorsen - CFOSvein Moxnes Harfjeld - President and CEOConference Call ParticipantsFrode Mørkedal - Senior Equity AnalystOperatorGood day, and thank you for standing by. Welcome to the Q4 2025 DHT Holdings, Inc. earnings conference call. At this time, all participants are in a listen-only m ...

Embecta (NasdaqGS:EMBC) Q1 2026 Earnings call February 05, 2026 08:00 AM ET Company ParticipantsDevdatt Kurdikar - CEOJake Elguicze - CFOPravesh Khandelwal - VP of Investor RelationsRyan Schiller - Equity Research AssociateConference Call ParticipantsNone - AnalystNone - AnalystOperatorWelcome, ladies and gentlemen, to the Embecta Corp.'s fiscal first quarter 2026 earnings conference call. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being r ...